Anti-GP2 (Glycoprotein 2) (Human) mAb (Clone: 3G7-H9)

MBL

Catalog No: MBL-D277-3

Browse all MBL products from our MBL products homepage.

Monoclonal antibody of 100 µl targeting GP2 for FCM, ICC, IHC.

Product Specifications

• Application: FC, ICC, IHC
• Reactivity: Human
• Clonality: Monoclonal IgG1 ĸ
• Host: Mouse
• Immunogen: Human Fc fusion protein of human GP2 quality except the transmembrane region
• Formulation: 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained.

Citations for Anti-GP2 (Glycoprotein 2) (Human) mAb (Clone: 3G7-H9) – 5 Found

Hase, Koji; Kawano, Kazuya; Nochi, Tomonori; Pontes, Gemilson Soares; Fukuda, Shinji; Ebisawa, Masashi; Kadokura, Kazunori; Tobe, Toru; Fujimura, Yumiko; Kawano, Sayaka; Yabashi, Atsuko; Waguri, Satoshi; Nakato, Gaku; Kimura, Shunsuke; Murakami, Takaya; Iimura, Mitsutoshi; Hamura, Kimiyo; Fukuoka, Shin-Ichi; Lowe, Anson W; Itoh, Kikuji; Kiyono, Hiroshi; Ohno, Hiroshi. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature. 2009;462(7270):226-30. 

Kunisawa, Jun; Kurashima, Yosuke; Kiyono, Hiroshi. Gut-associated lymphoid tissues for the development of oral vaccines. Advanced Drug Delivery Reviews. 2012;64(6):523-30. 

Kujala, Pekka; Raymond, Claudine R; Romeijn, Martijn; Godsave, Susan F; van Kasteren, Sander I; Wille, Holger; Prusiner, Stanley B; Mabbott, Neil A; Peters, Peter J. Prion uptake in the gut: identification of the first uptake and replication sites. Plos Pathogens. 2011;7(12):e1002449. 
- Comments: Used in: IF

Hayashi, Hiroko; Ohtani, Masashi; Sada, Yuki; Iwasaki, Keisuke; Shimokawa, Isao. GALT carcinoma: three case reports with glycoprotein 2 immunohistochemistry and electron microscopic observations. Histopathology. 2018;73(3):521-528. 
- Comments: Used in: IHC

Ranganathan, Sridevi; Doucet, Michele; Grassel, Christen L; Delaine-Elias, BreOnna; Zachos, Nicholas C; Barry, Eileen M. Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model. Infection And Immunity. 2019;87(4) 
- Comments: Used in: IHC